Global Transfection (Gene Delivery, DNA Delivery, Protein Delivery, SiRNA Delivery) Technologies Market (2012 – 2017)
DUBLIN, June 28, 2013 /PRNewswire/ –
Research and Markets ( http://www.researchandmarkets.com/research/42wzs7/global)
has announced the addition of the “Global Transfection (Gene Delivery, DNA Delivery,
Protein Delivery, SiRNA Delivery) Technologies (Lipofection, Calcium Phosphate,
Electroporation, Nucleofection, Magnetofection, Gene Gun, Viral) Market (2012 – 2017)”
[http://www.researchandmarkets.com/research/42wzs7/global ] report to their offering.
Transfection is an enabler technology used for many cell based research activities
with applications spanning production of recombinant proteins and recombinant cell lines,
gene therapy, delivery of therapeutics and also drug discovery. This research report
provides a brief description on transfection technologies, its evolution, comparative
analysis, market landscape analysis, competitive scenario and emerging technology and
application trends. Global research and development Network, Innovation and Spin offs have
been discussed. The report tracks regional adoption and development trends, providing
strategic recommendation to stay active and compete in the market space. An impact
analysis of major drivers and restraints influencing the growth of the market is mapped
for five year period.
Advances in cell research and therapeutic delivery
Cell research is a major driving factor for transfection market, as more than 60% of
the users are of academic institutions and researchers. Research in gene transfer is being
performed in in vivo conditions for different therapeutic applications; there is a growing
demand for new transfection technologies to address unmet needs for therapeutic delivery
which is driving the transfection market.
Home brew Reagents restricts sale of commercial kits
Home brew reagents are still the preferred choice of reagents for transfection by
researchers all over the world. Most of the researchers prepare their own reagents from
their laboratory to conduct their research. This is true for most of the reagent based
transfection reactions. This allows them to reduce cost involved in purchasing commercial
New disruptive technologies required to address transfection in hard-to-transfect
Transfection [http://www.researchandmarkets.com/research/42wzs7/global ] is an enabler
technology which is used in many cell research activities, however only few cell lines are
majorly used in these experiments restricting the scope of the study. Transfection in hard
to transfect cells is the need of hour and it is a major challenge. There are few upcoming
transfection technologies like nucleofection and magnetofection – which are an off-shoot
of electroporation, which have the potential to address these challenges but are currently
cost prohibitive due to which the technologies may have a much slower uptake in the
Key Topics Covered:
2. Executive Summary
3. Transfection Technologies – Technology Landscape Analysis
4. Transfection – Market Landscape Analysis
5. Global R&D Portfolio Analysis
6. Investment/Funding Analysis
7. Transfection – Diffusion Analysis
8. Competitive Landscape
9. Opportunity Evaluation And Technology Benchmarking/Roadmapping
10. Patent Analysis
11. Analyst Insights And Recommendations
12. Company Profiles
– Life Technologies Corporation
- Lonza Group Ltd.
- Promega Corporation
- Sigma Aldrich Corporation
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories Inc.
- Roche Applied Science
- Qiagen N.V.,
- Inovio Pharmaceuticals Inc.,
- Polyplus Transfection S.A.
- Mirus Bio Llc.
- Clonetech Laboratories, Inc.
- Signagen Laboratories
- Maxcyte, Inc.
- Techulon Inc.,
- Deliverics Ltd.
- Oz Biosciences
- Molecular Transfer Inc.,
- Altogen Biosystems
- Promokine Gmbh
For more information visit
Research and Markets Laura Wood, Senior Manager. email@example.com U.S. Fax: +1-646-607-1907 Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets